Aquestive Therapeutics
AQST
AQST
57 hedge funds and large institutions have $90M invested in Aquestive Therapeutics in 2020 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
24% more call options, than puts
Call options by funds: $671K | Put options by funds: $542K
7.55% more ownership
Funds ownership: 47.58% → 55.13% (+7.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
57
Holding in Top 10
2
Calls
$671K
Puts
$542K
Top Buyers
| 1 | +$8.51M | |
| 2 | +$5.9M | |
| 3 | +$1.4M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$926K |
| 5 |
Squarepoint
New York
|
+$862K |
Top Sellers
| 1 | -$1.96M | |
| 2 | -$1.2M | |
| 3 | -$657K | |
| 4 |
Renaissance Technologies
New York
|
-$644K |
| 5 |
Millennium Management
New York
|
-$405K |